MANILA, Philippines — The Department of Health (DOH) announced on Friday the official resumption of vaccination with AstraZeneca’s COVID-19 vaccine for all eligible population.
The DOH previously adopted the recommendation of the Food and Drug Administration (FDA) to temporarily suspend, pending review, the use of AstraZeneca shots for those aged below 60 years old following reports of very rare cases of Vaccine-Induced Thrombosis and Thrombocytopenia (VITT).
VITT is a very rare condition of blood clots associated with low platelet counts that can occur four to 28 days after receiving a viral vector vaccine such as AstraZeneca.
“After discussions with the DOH All Exp…
Keep on reading: DOH officially resumes AstraZeneca COVID-19 vaccination